[524] 10 Cannabis-Based Drugs Produced By Big Pharma. https://herb.co/marijuana/news/cannabis-based-drugs-big-pharma
[525] Dagfinn Haarr, Sofie Haughom: Marihuana er effektiv medisin.http://www.aftenposten.no/meninger/kronikker/Kronikk-Marihuana-er-effektiv-medisin—Dagfinn-Haarr_-Sofie-Haughom-8378238.html
[526] Cannabis får kræftceller til at begå selvmord. http://www.ladanesa.com/temaadebat/43-nyheder/temaadebat/4818-cannabis-far-kraeftceller-til-at-bega-selvmord
[527] What Are The Medical Benefits of Marijuana? https://www.leafscience.com/2017/10/13/medical-benefits-marijuana/
What Exactly Is Unconstitutional About Plans To Limit THC? https://herb.co/marijuana/news/what-exactly-is-unconstitutional-about-plans-to-limit-thc
What is Sativex (Nabiximols).https://www.leafscience.com/2017/11/02/what-is-sativex-nabiximols/
John M. McPartland, Ethan B. Russo: Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? https://www.cannabis-med.org/data/pdf/2001-03-04-7.pdf
[528] Howard P, Twycross R, Shuster J, et al.: Cannabinoids. J Pain Symptom Manage 46 (1): 142-9, 2013. [PUBMED Abstract]. http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#link/_45_toc
[529] Ordination af medicinsk cannabis. https://www.sundhed.dk/sundhedsfaglig/information-til-praksis/sjaelland/almen-praksis/laegemidler/medicinsk-cannabis/
[530] Derick T Wade, Christine Collin, Colin Stott et al.: Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Multiple Sclerosis Journal Vol 16, Issue 6, 2010. http://journals.sagepub.com/doi/abs/10.1177/135245851036746
[531] Collin C1, Davies P, Mutiboko IK. Et al.: Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol. 2007 Mar;14(3):290-6. https://www.ncbi.nlm.nih.gov/pubmed/17355549
[532] Portenoy RK1, Ganae-Motan ED, Allende S. et al.: Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012 May;13(5):438-49. doi: 10.1016/j.jpain.2012.01.003. Epub 2012 Apr 5. https://www.ncbi.nlm.nih.gov/pubmed/22483680
[533] 6 Takeaways From Dr. Ethan Russo’s ‘Cannabis: An Unconventional Solution to the Opioid Crisis’.https://www.leafly.com/news/health/6-takeaways-from-dr-ethan-russos-cannabis-an-unconventional-solution-to-the-opioid-crisis
What is Sativex (Nabiximols).https://www.leafscience.com/2017/11/02/what-is-sativex-nabiximols/
[534] Turo J.Nurmikko, Mick G.Serpell, BarbaraHoggart et al.: Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial. PAIN® Volume 133, Issues 1–3, 15 December 2007, Pages 210-220. https://www.sciencedirect.com/science/article/pii/S0304395907004642
[535] Ethan B. Russo, Geoffrey W. Guy, Philip J. Robson: Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine. Chemistry & Diversity Volume4, Issue8 August 2007 Pages 1729-1743. https://onlinelibrary.wiley.com/doi/abs/10.1002/cbdv.200790150
[536] Blake DR1, Robson P, Ho M. et al.: Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006 Jan;45(1):50-2. Epub 2005 Nov 9. https://www.ncbi.nlm.nih.gov/pubmed/16282192
[537] Kavia RB1, De Ridder D, Constantinescu CS. Et al.: Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler. 2010 Nov;16(11):1349-59. doi: 10.1177/1352458510378020. Epub 2010 Sep 9. https://www.ncbi.nlm.nih.gov/pubmed/20829244
[538] Berman JS1, Symonds C, Birch R.: Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain. 2004 Dec;112(3):299-306. https://www.ncbi.nlm.nih.gov/pubmed/15561385
[539] Jürgen Koehler, Wolfgang Feneberg, Martin Meier: Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity. Journal International Journal of Neuroscience Volume 124, 2014 – Issue 9. https://www.tandfonline.com/doi/abs/10.3109/00207454.2013.877460
[540] Marijuana and Anxiety: A Guide. https://www.leafscience.com/2017/05/10/marijuana-and-anxiety-a-guide/
[541] Why Does Marijuana Make You Paranoid? https://www.leafscience.com/2017/09/05/marijuana-make-paranoid/
[542] Sativex Oromucosal Spray. https://www.medicines.org.uk/emc/medicine/23262
[543] GW’s Epidiolex® Clinical Program. https://www.gwpharm.com/epilepsy-patients-caregivers/patients
[544] https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf
GW Announces New Epidiolex® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome. http://ir.gwpharm.com/releasedetail.cfm?releaseid=1002552
[545] Marijuana and muscle spasms. https://herb.co/marijuana/news/marijuana-and-muscle-spasms
How to Use Cannabis Tincture. https://zenpype.com/how-to-use-cannabis-tincture/
Medical Marijuana and Epilepsy. https://www.epilepsy.com/learn/treating-seizures-and-epilepsy/other-treatment-approaches/medical-marijuana-and-epilepsy
[546] FDA and Marijuana: Questions and Answers. https://www.fda.gov/newsevents/publichealthfocus/ucm421168.htm#use
Three Different Cannabinoid-Based Medicines Approved by the FDA https://www.medicaljane.com/2017/05/01/the-3-cannabis-based-medicines-approved-by-the-fda/
[547] What is THC (Tetrahydrocannabinol)?https://www.leafscience.com/2017/11/09/what-is-thc-tetrahydrocannabinol/
[548] Tetrahydrocannabinol (THC). https://www.medicaljane.com/cannabinoid/thc/
[549] Marinol VS THC: What’s The Difference? https://herb.co/marijuana/news/marinol-vs-thc-whats-difference
How Is Synthetic Weed Legal When It Kills? https://herb.co/marijuana/news/how-is-synthetic-weed-legal-when-it-kills
What is Marinol (Dronabinol).https://www.leafscience.com/2017/10/23/what-is-marinol-dronabinol/
[550] Marinol. https://bodyandhealth.canada.com/drug/getdrug/marinol
Medical MariJuana: Furthering an Objective Debate. Canadian Journal Addiction. Volume 4 Number 3. https://www.csam-smca.org/wp-content/uploads/2013/09/CJA_Journal_September_2013.pdf
[551] Tramèr MR1, Carroll D, Campbell FA. Et al.: Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001 Jul 7;323(7303):16-21. https://www.ncbi.nlm.nih.gov/pubmed/11440936
[552] Gorter R, Seefried M, Volberding P: Dronabinol effects on weight in patients with HIV infection. AIDS 6 (1): 127, 1992. https://www.ncbi.nlm.nih.gov/pubmed/1311935
Beal JE, Olson R, Laubenstein L, et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10 (2): 89-97, 1995. http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
What is Marinol (Dronabinol)? https://www.leafscience.com/2017/10/23/what-is-marinol-dronabinol/
Drugs@FDA: FDA Approved Drug Products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=018651
Medical Marijuana vs. Marinol. https://www.marijuanadoctors.com/blog/medical-marijuana-vs-marinol/?utm_content=buffer29bcf&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer
What Are The Medical Benefits of Marijuana? https://www.leafscience.com/2017/10/13/medical-benefits-marijuana/
Sallan SE, Zinberg NE, Frei E 3rd: Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 293 (16): 795-7, 1975. [PUBMED Abstract] http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#link/_45_toc http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
[553] Jeffrey E.Beal, Richard Olson, Linda Laubenstein et al.: Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain and Symptom Management Volume 10, Issue 2, February 1995, Pages 89-97. https://www.sciencedirect.com/science/article/pii/0885392494001174
[554] Narang S1, Gibson D, Wasan AD, Ross EL et al.: Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain. 2008 Mar;9(3):254-64. Epub 2007 Dec 21. https://www.ncbi.nlm.nih.gov/pubmed/18088560
Medical Marijuana and Chronic Pain. https://www.marijuanadoctors.com/conditions/chronic-pain/
[555] Medical Marijuana and Fibromyalgia. https://www.marijuanadoctors.com/conditions/fibromyalgia/
Schley M1, Legler A, Skopp G. et al.: Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr Med Res Opin. 2006 Jul;22(7):1269-76. https://www.ncbi.nlm.nih.gov/pubmed/16834825
[556] Medical Marijuana and Multiple Sclerosis (MS). https://www.marijuanadoctors.com/conditions/multiple-sclerosis-ms/
Svendsen KB1, Jensen TS, Bach FW.: Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ. 2004 Jul 31;329(7460):253. Epub 2004 Jul 16. https://www.ncbi.nlm.nih.gov/pubmed/15258006
[557] Carter GT1, Abood ME, Aggarwal SK, Weiss MD: Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. Am J Hosp Palliat Care. 2010 Aug;27(5):347-56. doi: 10.1177/1049909110369531. Epub 2010 May 3. https://www.ncbi.nlm.nih.gov/pubmed/20439484
Medical Marijuana and Amyotrophic Lateral Sclerosis (ALS). https://www.marijuanadoctors.com/conditions/amyotrophic-lateral-sclerosis-als/
[558] Prasad B1, Radulovacki MG, Carley DW: Proof of concept trial of dronabinol in obstructive sleep apnea. Front Psychiatry. 2013 Jan 22;4:1. doi: 10.3389/fpsyt.2013.00001. eCollection 2013. https://www.ncbi.nlm.nih.gov/pubmed/23346060
Medical Marijuana and Sleep Apnea. https://www.marijuanadoctors.com/conditions/sleep-apnea/
[559] Volicer L1, Stelly M, Morris J, McLaughlin J. et al.: Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 1997 Sep;12(9):913-9. https://www.ncbi.nlm.nih.gov/pubmed/9309469
Medical Marijuana and Dementia. https://www.marijuanadoctors.com/conditions/dementia/
[560] Christine A.,Rabinaka Mike, Angstadta Chandra, S.Sripada et al.: Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology Volume 64, January 2013, Pages 396-402. https://www.sciencedirect.com/science/article/pii/S0028390812003371
Synthetic THC May Help in the Treatment of Phobias. https://www.medicaljane.com/2013/08/05/american-study-tetrahydrocannabinol-thc-may-help-phobia-treatment/
[561] Ordination af medicinsk cannabis. https://www.sundhed.dk/sundhedsfaglig/information-til-praksis/sjaelland/almen-praksis/laegemidler/medicinsk-cannabis/
[562] Medicinsk cannabis og cannabisbaseret medicin https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/sundhedsoplysning/sundhedsoplysning/diverse/medicinsk-cannabis/
[563] Drugs@FDA: FDA Approved Drug Products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=205525
[564] Is a maker of deadly painkillers bankrolling the opposition of Arizona marijuana legalization? http://www.thecannabist.co/2016/09/12/arizona-marijuana-insys-therapeutics/62986/
[565] The non-weed biz world is zeroing in on legalization. http://www.thecannabist.co/2016/11/02/marijuana-legalization-business-risk-factor-sec-public-companies/66480/
[566] Billionaire John Kapoor of Insys Therapeutics Arrested in Phoenix on Opioid Charges. http://www.phoenixnewtimes.com/news/billionaire-john-kapoor-of-insys-therapeutics-arrested-in-phoenix-on-opioid-charges-9813260
Opioid maker settles lawsuit over fentanyl spray. http://www.unionleader.com/courts/Opioid-maker-settles-lawsuit-over-fentanyl-spray-01182017
http://www.chicagotribune.com/business/ct-subsys-opioid-lawsuit-0826-biz-20160825-story.html
Attorney General Brings Enforcement Action Against Opioid Pharmaceutical Company Insys Therapeutics For Its Unfair And Deceptive Marketing Practices Of Its Fentanyl Drug Subsys. https://www.doj.nh.gov/media-center/press-releases/2017/20170118-insys.htm
Dose of Justice. https://news.vice.com/en_ca/article/bjdw53/ex-pharma-executives-arrested-for-allegedly-bribing-doctors-to-prescribe-fentanyl
[567] Insys founder Kapoor sued by New Jersey over opioid marketing campaign. https://www.azcentral.com/story/money/business/health/2017/11/20/insys-founder-john-kapoor-sued-new-jersey-over-opioid-marketing-campaign/880646001/
[568] Medicinsk cannabis og cannabisbaseret medicin https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/sundhedsoplysning/sundhedsoplysning/diverse/medicinsk-cannabis/
[569] Drugs@FDA: FDA Approved Drug Products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=018677
[570] What is the entourage effect? https://www.medicaljane.com/question/what-is-the-weed-entourage-effect-of-medical-marijuana/
DR. ETHAN RUSSO: CBD & CLINICAL ENDOCANNABINOID DEFICIENCY https://www.projectcbd.org/science/cannabis-pharmacology/dr-ethan-russo-cbd-clinical-endocannabinoid-deficiency
[571]Medicinsk cannabis og cannabisbaseret medicin. https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/sundhedsoplysning/sundhedsoplysning/diverse/medicinsk-cannabis/
[572] Berlach, D. M., Shir, Y., and Ware, M. A. (2006). Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. Pain Med. 7: 25-29. https://www.ncbi.nlm.nih.gov/pubmed/16533193
[573] Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D (2008). Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ,336:199. doi: 10.1136/bmj.39429.619653.80. https://www.ncbi.nlm.nih.gov/pubmed/18182416
Toth, C., Mawani, S., Brady, S., Chan, C. and others. (2012). An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain. 153: 2073-2082. https://www.ncbi.nlm.nih.gov/pubmed/22921260
[574] Ware, M. A., Fitzcharles, M. A., Joseph, L., and Shir, Y. (2010). The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth.Analg. 110: 604-610. https://www.ncbi.nlm.nih.gov/pubmed/20007734
Skrabek, R. Q., Galimova, L., Ethans, K., and Perry, D. (2008). Nabilone for the treatment of pain in fibromyalgia. J.Pain. 9: 164-173. https://www.ncbi.nlm.nih.gov/pubmed/17974490
[575] Fraser, G. A. (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS.Neurosci.Ther. 15: 84-88. https://www.ncbi.nlm.nih.gov/pubmed/19228182
[576] Pooyania, S., Ethans, K., Szturm, T., Casey, A. and others. (2010). A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch.Phys.Med.Rehabil. 91: 703-707. https://www.ncbi.nlm.nih.gov/pubmed/20434606
[577] Marinol vs. Natural Plant. http://norml.org/component/zoo/category/marinol-vs-natural-cannabis
[578] Cannabis Cannabinoids. https://www.marijuanadoctors.com/resources/cannabinoids/
[579] Marijuana Terpenes Guide. https://www.marijuanadoctors.com/resources/medical-marijuana-terpenes/
[580] Russo E1, Guy GW: A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66(2):234-46. Epub 2005 Oct 4. https://www.ncbi.nlm.nih.gov/pubmed/16209908
[581] Ethan B Russo: Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011 Aug; 163(7): 1344–1364. doi: 10.1111/j.1476-5381.2011.01238.x.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
[582] Physician’s Desk Reference: 43rd edition. Medical Economics Company. 1989: 1859-1860.
[583] Physician’s Desk Reference: 52nd edition. Medical Economics Company. 1998: 2353-2355.
[584] National Academy of Sciences, Institute of Medicine. 1999. Marijuana and medicine: Assessing the Science Base. p. 203. 1999. Washington, DC: The National Academies Press. https://doi.org/10.17226/6376 .
[585] J. Morgan and L. Zimmer, Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence. The Lindesmith Center. 1997: 18-19. https://www.bisdro.uni-bremen.de/boellinger/cannabis/08-zi-mo.pdf
[586] L. Lemberger et al. 1973. Comparative pharmacology of delta-9-THC and its metabolite 11-0H-Delta-9-THC. Journal of Clinical Investigation 54: 2411-2417. https://www.ncbi.nlm.nih.gov/pubmed/4729039
M. Perez-Reyes et al. 1972. Intravenous injection in man of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol. Science 177: 633-635. https://www.ncbi.nlm.nih.gov/pubmed/4558903
[587] L. Growing et al. 1998. Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review. 17: 445-452. https://www.researchgate.net/publication/237718296_Drug_and_Alcohol_Services_Council_DASC_South_Australia_Therapeutic_Uses_of_Cannabis
[588] J. Morgan and L. Zimmer, Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence, 19. https://www.bisdro.uni-bremen.de/boellinger/cannabis/08-zi-mo.pdf
[589] G. Carter et al. 2004. Medical marijuana: emerging applications for the management of neurologic disorders. https://europepmc.org/abstract/med/15458761
A. Zuardi et al. 1982. Action of cannabidiol on the anxiety and other effects produced by delta-9-THC in normal subjects. Psychopharmacology 76: 245-250. https://www.ncbi.nlm.nih.gov/pubmed/6285406
G. Karinol et al. 1974. Cannabidiol interferes with the effects of delta-9-tetrahydrocannabinol in man. European Journal of Pharmacology 28: 172-177. https://www.sciencedirect.com/science/article/pii/0014299974901290
[590] D. Gieringer et al. 2004. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. Journal of Cannabis Therapeutics 4: 7-27. https://www.tandfonline.com/doi/abs/10.1300/J175v04n01_02
[591] L. Growing et al. 1998. Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review.
[592] National Academy of Sciences, Institute of Medicine. Of Marinol’s patient population, only about 10 percent use it to combat cancer-related nausea. 1999. Marijuana and Medicine: Assessing the Science Base. p. 204.
[593] E. Woolridge et al. 2005. Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management 29: 358-67. https://www.ncbi.nlm.nih.gov/pubmed/15857739
[594] J. McPartland and E. Russo. 2002. Cannabis and cannabis extracts: greater than the sum of their parts. Journal of Cannabis Therapeutics. https://www.researchgate.net/publication/228897917_Cannabis_and_cannabis_extracts_Greater_than_the_sum_of_their_parts
[595] Marijuana-like compound may aid array of debilitating conditions ranging from Parkinson’s Disease to pain. Society for Neuroscience. October 26, 2004. ScienceDaily. ScienceDaily, 27 October 2004. www.sciencedaily.com/releases/2004/10/041027102621.htm
[596] Pryce et al. 2003. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain. 126: 2191-2202. https://www.ncbi.nlm.nih.gov/pubmed/12876144
[597] C. Raman et al. 2004. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 5: 33-39. https://www.ncbi.nlm.nih.gov/pubmed/15204022
[598] I. Lastres-Becker et al. 2003. Effects of cannabinoids in the rat model of Huntington’s disease generated by an intrastraital injection of malonate. Neuroreport 14: 813-816. https://www.ncbi.nlm.nih.gov/pubmed/12858038
[599] Ruth Gallily1, Zhannah Yekhtin1, Lumír Ondřej Hanuš: Overcoming the Bell‐Shaped
Dose‐Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol. Pharmacology & Pharmacy, 2015, 6, 75‐85. Published Online February 2015 in SciRes. http://www.scirp.org/journal/pphttp://dx.doi.org/10.4236/pp.2015.62010
Synthetic vs. Whole Plant CBD. https://www.projectcbd.org/article/synthetic-vs-whole-plant-cbd
[600] Conditions. https://www.projectcbd.org/guidance/conditions
Taming THC. https://www.projectcbd.org/about/cannabis-pharmacology/taming-thc
[601] Tale of Two Cannabinoids. https://www.projectcbd.org/about/cannabis-pharmacology/tale-two-cannabinoids
[602] E. Williamson. 2001. Synergy and other interactions in phytomedicines. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 8: 401-409. https://www.ncbi.nlm.nih.gov/pubmed/11695885
[603] A. Holdcroft. 2001. Cannabinoids: from plant to patient. Investigative Drugs Journal. 4: 773-775. https://www.ncbi.nlm.nih.gov/pubmed/15995932
[604] J. McPartland and E. Russo. 2002. Cannabis and cannabis extracts: greater than the sum of their parts. Journal of Cannabis Therapeutics. p. 103. https://www.researchgate.net/publication/228897917_Cannabis_and_cannabis_extracts_Greater_than_the_sum_of_their_parts
[605] The Pharmaceutical Journal. “Cannabis herb may have advantages over THC in epilepsy.” July 19, 2003.
[606] D. Wade et al. 2004. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Multiple Sclerosis 2004 Aug;10(4):434-41. https://www.ncbi.nlm.nih.gov/pubmed/15327042
J. Zajicek et al. 2003. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis. Lancet. 362: 1517-26. https://www.ncbi.nlm.nih.gov/pubmed/14615106
[607] Paul Armentano: Marinol Versus Natural Cannabis. Pros, Cons and Options for Patients. The National Organization for the Reform of Marijuana Laws. http://norml.org/pdf_files/NORML_Marinol_vs_Natural_Cannabis.pdf
[608] R. Musty and R. Rossi. 2001. Effects of smoked cannabis and oral delta-9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: a review of state clinical trials. Journal of Cannabis Therapeutics. 1: 29-56. http://www.cannabis-med.org/iacm/data/pdf/2001-01-2.pdf
[609] Board of Pharmacy, State of Tennessee. 1983. Annual Report: Evaluation of Marijuana and Tetrahydrocannabinol in Treatment of Nausea and/or Vomiting Associated with Cancer Therapy Unresponsive to Conventional Anti-Emetic Therapy: Efficacy and Toxicity. p. 5. https://www.epistemonikos.org/en/documents/0ae184c24b15d7d0e026fb727d608fdd07cc35ae
[610] Behavioral Health Services Division. 1983. The Lynn Pierson Therapeutic Research Program: A Report on Progress to Date. Health and Environment Department: New Mexico. p. 4. https://medicalmarijuana.procon.org/sourcefiles/new-mexico-progress-report-1983.pdf
[611] R. Schwartz and R. Beveridge. 1994. Marijuana as an antiemetic drug: how useful today. Opinions from clinical oncologists. Journal of Addictive Diseases 13: 53-65. https://www.ncbi.nlm.nih.gov/pubmed/7503819
[612] R. Doblin and M. Kleiman. 1991. Marijuana as an anti-emetic medicine: a survey of oncologists’ attitudes and experiences. Journal of Clinical Oncology 19: 1275-1290. https://www.ncbi.nlm.nih.gov/pubmed/2045870
[613] Research Advisory Panel. 1986. Seventeenth Annual Report of the Research Advisory Panel, p. 9-10.
[614] V. Vinciguerra et al. 1988. Inhalation marijuana as an antiemetic for cancer chemotherapy. New York State Journal of Medicine 88: 525-527. https://www.researchgate.net/publication/19925671_Inhalation_marijuana_as_an_antiemetic_for_cancer_chemotherapy
[615] E. Woolridge et al. 2005. Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management. https://www.ncbi.nlm.nih.gov/pubmed/15857739
[616] D. Prentiss et al. 2004. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. Journal of Acquired Immune Definiciency Syndromes 35: 38-45. https://www.ncbi.nlm.nih.gov/pubmed/14707790
[617] R. Gorter et al. 2005. Medical use of cannabis in the Netherlands. Neurology 64: 917-919. https://www.ncbi.nlm.nih.gov/pubmed/15753439
[618] Reuters News Wire. “Marijuana helps MS patients alleviate pain, spasms.” August 19, 2002.
Multiple Sclerosis. http://norml.org/library/item/multiple-sclerosis#b20
[619] S. Page et al. 2003. Cannabis use as described by people with multiple sclerosis. Canadian Journal of Neurological Sciences 30: 201-205. https://www.ncbi.nlm.nih.gov/pubmed/12945941
[620] A. Clark et al. 2004. Patterns of cannabis use among patients with multiple sclerosis. Neurology 62: 2098-2100. https://www.ncbi.nlm.nih.gov/pubmed/15184623
[621] D. Gross et al. 2004. Marijuana use and epilepsy. Neurology 62: 2095-2097. http://n.neurology.org/content/62/11/2095
[622] News Wire. “Pot may ease Parkinson’s symptoms — Czech study.” November 13, 2002.
[623] Hazekamp A1, Ware MA, Muller-Vahl KR. et al.: The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms. J Psychoactive Drugs. 2013 Jul-Aug;45(3):199-210. https://www.ncbi.nlm.nih.gov/pubmed/24175484